BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22483766)

  • 1. [Development of synergies and partnerships on rare diseases: model of a scientific cooperation foundation].
    Lévy N
    Presse Med; 2012 May; 41 Suppl 1():S23-5. PubMed ID: 22483766
    [No Abstract]   [Full Text] [Related]  

  • 2. Alzheimer's disease public-private partnerships: A landscape of the global nonprofit community.
    Snyder HM; Bain LJ; Egge R; Carrillo MC
    Alzheimers Dement; 2013 Jul; 9(4):466-71. PubMed ID: 23809367
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interest in partnerships around the Mediterranean basin for rare diseases].
    Mégarbané A
    Presse Med; 2012 May; 41 Suppl 1():S51-4. PubMed ID: 22459993
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mediterranean region debate-what are the existing partnerships? What are the ones missing?].
    Med Sci (Paris); 2014 Apr; 30 Spe(1):40-6. PubMed ID: 24755178
    [No Abstract]   [Full Text] [Related]  

  • 5. Europe's innovation hub finally KICs off.
    Gilbert N
    Nature; 2011 Feb; 470(7335):450. PubMed ID: 21350459
    [No Abstract]   [Full Text] [Related]  

  • 6. Academia-pharma partnerships for novel drug discovery: essential or nice to have?
    Palmer M; Chaguturu R
    Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189
    [No Abstract]   [Full Text] [Related]  

  • 7. Funding bodies should foster partnerships between industry and academia.
    Tzircotis G; Hickson T; Foulkes I
    Nat Rev Cancer; 2021 Feb; 21(2):65-66. PubMed ID: 33398101
    [No Abstract]   [Full Text] [Related]  

  • 8. The CNCCS, a benchmark Italian consortium for bioeconomy and an opportunity for the Istituto Superiore di Sanità.
    Ingrosso L; Rezza G; Pocchiari M; Garaci E
    Ann Ist Super Sanita; 2012; 48(2):115-6. PubMed ID: 22751551
    [No Abstract]   [Full Text] [Related]  

  • 9. Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry.
    Zhang Z; Jia M; Wan D
    Int J Health Care Finance Econ; 2009 Jun; 9(2):169-82. PubMed ID: 19360467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A transformative program, ahead of its time.
    Ladden M; Maher N
    Nurs Outlook; 2014; 62(6):482-90. PubMed ID: 25455709
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cohorts and registers: Which public/private partnerships to choose?].
    Jouan-Flahault C; Landais P; Thomas R; Parker S; Genevaz D
    Presse Med; 2012 May; 41 Suppl 1():S15-9. PubMed ID: 22464892
    [No Abstract]   [Full Text] [Related]  

  • 12. New and evolving rare diseases research programs at the National Institutes of Health.
    Groft SC; Rubinstein YR
    Public Health Genomics; 2013; 16(6):259-67. PubMed ID: 24503586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creative cross-organizational collaboration: coming to a project near you.
    Reeve BC
    Regen Med; 2012 Mar; 7(2):237-43. PubMed ID: 22236251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foundation-industry relationships--a new business model joint-venture philanthropy in therapy development.
    Bartek RJ
    Curr Top Med Chem; 2014; 14(3):313-8. PubMed ID: 24283968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. School-Based Health Centers: A Funder's View Of Effective Grant Making.
    Sprigg SM; Wolgin F; Chubinski J; Keller K
    Health Aff (Millwood); 2017 Apr; 36(4):768-772. PubMed ID: 28373343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research foundations. Biochemist Robert Tjian named president of Hughes Institute.
    Kaiser J
    Science; 2008 Oct; 322(5898):35. PubMed ID: 18832621
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynasty Foundation: Russian science loses to politics.
    Kondrashov FA; Kondrashov AS; Gelfand MS
    Nature; 2015 Jun; 522(7557):419. PubMed ID: 26108844
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical research. Advocating, the clinical way.
    Couzin J
    Science; 2005 May; 308(5724):940-2. PubMed ID: 15890856
    [No Abstract]   [Full Text] [Related]  

  • 19. Advancing health through sustained collaboration: how the history of corporate relations extended the Academy's reach.
    Stein K
    J Acad Nutr Diet; 2015 Jan; 115(1):131-42. PubMed ID: 25534896
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomedical research funding. Battle of the titans.
    Macilwain C
    Science; 2010 May; 328(5981):964-7. PubMed ID: 20489001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.